Krishnaswamy Yeleswaram, Chief Development Officer at Rapport Therapeutics, Inc. (RAPP), sold 2,840 shares at $30.05 ($85K) on 2025-12-31, disclosed to the SEC on 2026-01-05.
Open-market sale of $85k RAPP by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RAPP | SELL | 2026-04-21 | $809K | — | Filing → |
| RAPP | SELL | 2026-04-14 | $696K | — | Filing → |
| RAPP | SELL | 2026-04-09 | $13K | — | Filing → |